Nikhil Kamath

795 total citations · 1 hit paper
11 papers, 544 citations indexed

About

Nikhil Kamath is a scholar working on Pulmonary and Respiratory Medicine, Immunology and Surgery. According to data from OpenAlex, Nikhil Kamath has authored 11 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 3 papers in Immunology and 2 papers in Surgery. Recurrent topics in Nikhil Kamath's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers), Inhalation and Respiratory Drug Delivery (3 papers) and Biomarkers in Disease Mechanisms (2 papers). Nikhil Kamath is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers), Inhalation and Respiratory Drug Delivery (3 papers) and Biomarkers in Disease Mechanisms (2 papers). Nikhil Kamath collaborates with scholars based in United Kingdom, United States and Germany. Nikhil Kamath's co-authors include Piotr Kuna, Dennis K. Ledford, Mark Ashby, William Berger, Karin Rosén, Thilo Jakob, Joachim Veith, James L. Zazzali, Petra Staubach and Edward Conner and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Journal of Allergy and Clinical Immunology and Heart Rhythm.

In The Last Decade

Nikhil Kamath

10 papers receiving 536 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy

2013 392 citations Allen P. Kaplan, Dennis K. Ledford et al. Journal of Allergy and Clinical Immunology profile →

Peers

Countries citing papers authored by Nikhil Kamath

Since Specialization

Citations

This map shows the geographic impact of Nikhil Kamath's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nikhil Kamath with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nikhil Kamath more than expected).

Fields of papers citing papers by Nikhil Kamath

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nikhil Kamath. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nikhil Kamath. The network helps show where Nikhil Kamath may publish in the future.

Co-authorship network of co-authors of Nikhil Kamath

This figure shows the co-authorship network connecting the top 25 collaborators of Nikhil Kamath. A scholar is included among the top collaborators of Nikhil Kamath based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nikhil Kamath. Nikhil Kamath is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Emergency laparoscopic cholecystectomy for gall bladder volvulus presenting as acute abdomen in an octogenarian: A case report 2025 ·Journal of Minimal Access Surgery ·(unknown), (unknown), Nikhil Kamath, (unknown), (unknown), (unknown), (unknown)	0
2	A pilot study of ketamine among individuals with tobacco use disorder: tolerability and initial impact on tobacco use outcomes 2025 ·Journal of Addictive Diseases ·(unknown), (unknown), Nikhil Kamath, Alison Oliveto, Merideth A. Addicott	1
3	Zinpentraxin Alfa for Idiopathic Pulmonary Fibrosis: The Randomized Phase III STARSCAPE Trial 2024 ·American Journal of Respiratory and Critical Care Medicine ·Luca Richeldi, Courtney Schiffman, Jürgen Behr, Yoshikazu Inoue, Tamera J. Corte, Vincent Cottin, Gísli Jenkins, Steven D. Nathan, Ganesh Raghu, Simon Walsh, (unknown), Nikhil Kamath, Fernando J. Martínez	17
4	Idiopathic pulmonary fibrosis therapy development: a clinical pharmacology perspective 2023 ·Therapeutic Advances in Respiratory Disease ·(unknown), (unknown), (unknown), Nikhil Kamath, Lin Pan	5
5	Long-term evaluation of the safety and efficacy of recombinant human pentraxin-2 (rhPTX-2) in patients with idiopathic pulmonary fibrosis (IPF): an open-label extension study 2022 ·Respiratory Research ·Ganesh Raghu, Mark J. Hamblin, Alison Brown, Jeffrey A. Golden, Lawrence Ho, Marlies Wijsenbeek, Martina Vašáková, Alberto Pesci, Danielle Antin‐Ozerkis, Keith C. Meyer, Michael Kreuter, Tracy Burgess, Nikhil Kamath, Francis Donaldson, Luca Richeldi	25
6	Efficacy, safety, and tolerability of lebrikizumab in adolescent patients with uncontrolled asthma (ACOUSTICS) 2022 ·Clinical and Translational Allergy ·Stanley J. Szefler, Graham Roberts, Adalberto Sperb Rubin, Stefan Zielen, Piotr Kuna, Oral Alpan, Judith Anzures‐Cabrera, Qiang Chen, Cécile Holweg, (unknown), Wendy S. Putnam, John G. Matthews, Nikhil Kamath	22
7	Recombinant human pentraxin-2 for idiopathic pulmonary fibrosis: Design of STARSCAPE-OLE, a Phase III open label extension study 2021 ·Luca Richeldi, Kevin J. Anstrom, Jürgen Behr, Tamera J. Corte, Vincent Cottin, Gísli Jenkins, Nikhil Kamath, Yoshikazu Inoue, Lutaf Islam, Steven D. Nathan, Ganesh Raghu, (unknown), Simon Walsh, Fernando J. Martínez	1
8	Evaluation of inpatient postpartum recovery using the Obstetric Quality of Recovery-10 patient-reported outcome measure: a single-center observational study 2020 ·American Journal of Obstetrics & Gynecology MFM ·Pervez Sultan, Nikhil Kamath, Brendan Carvalho, (unknown), (unknown), Scott T. Dougan, Julie R. Whittington, Nan Guo, Yasser El‐Sayed, Jill M. Mhyre, Nadir Sharawi	46
9	Rapid Lung Function Improvement with Lebrikizumab in Patients with Uncontrolled Asthma 2016 ·Journal of Allergy and Clinical Immunology ·Jonathan Corren, Nicola A. Hanania, Phillip E. Korenblat, (unknown), Nikhil Kamath, Sarah Gray, Nicolas Martin, Cécile Holweg, John G. Matthews, Susan L. Limb, Stephan Korom	2
10	Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy breakdown → 2013 ·Journal of Allergy and Clinical Immunology ·Allen P. Kaplan, Dennis K. Ledford, Mark Ashby, Janice Canvin, James L. Zazzali, Edward Conner, Joachim Veith, Nikhil Kamath, Petra Staubach, Thilo Jakob, Rob G. Stirling, Piotr Kuna, William Berger, Marcus Maurer, Karin Rosén	392
11	Cryoablation versus radiofrequency ablation for treatment of atrioventricular nodal reentrant tachycardia: Cryoablation with 6-mm-tip catheters is still less effective than radiofrequency ablation 2009 ·Heart Rhythm ·(unknown), (unknown), Nikhil Kamath, Mehul Dhinoja, Dominic J. Abrams, Simon Sporton, Richard J. Schilling, Mark J. Earley	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact